新利luck18英超|新利18官方网址

Skip to content THE SOURCE Close TopicsTopics Arts & Culture Business & Entrepreneurship Campus & Community Humanities & Society Medicine & Health Science & Technology SchoolsSchools Arts & Sciences Brown School McKelvey School of Engineering Olin Business School Sam Fox School of Design & Visual Arts School of Continuing & Professional Studies School of Law School of Medicine PublicationsPublications Newsroom The Record Washington Magazine Search Menu Search for: Search Close Medicine & Health All Medicine & Health Aging Alzheimer&＃039;s Cancer Research Medicine Mental Health Neuroscience & Memory Nutrition & Wellness Public Health Neuroscience & Memory Lucey receives sleep science award  Brendan P. Lucey, MD, a professor of neurology at the School of Medicine, has been awarded the 2024 Sleep Science Award from the American Academy of Neurology in recognition of his distinguished contributions to the neurology and neuroscience of sleep. June 14, 2024 Published In Record Alzheimer's Understanding role of T cells in Alzheimer’s disease is aim of new grant  Naresha Saligrama, an assistant professor of neurology at the School of Medicine, has received a $200,000 grant from the Cure Alzheimer’s Fund to investigate whether other aspects of the immune system also contribute to the disease, specifically T cells. June 14, 2024 Published In Record Alzheimer's Alzheimer’s biomarker sTREM2 plays a causal, potentially modifiable, role in disease  Carlos Cruchaga, a professor of psychiatry at the School of Medicine, has shown that the protein sTREM2 plays a causal role in the progression of Alzheimer’s disease, meaning that targeting the protein may affect the course of the disease. May 31, 2024 Published In Record Alzheimer's Tau protein deposition patterns predict Alzheimer’s severity  Researchers at the School of Medicine have devised a method to gauge Alzheimer’s disease severity by analyzing the patterns of tau pathology in brain scans. The findings could lead to a way to determine how far the disease has progressed in individuals. May 15, 2024 Published In Record Alzheimer's Alzheimer’s disease progresses faster in people with Down syndrome A new study by researchers at Washington University School of Medicine in St. Louis shows that Alzheimer&＃8217;s disease both starts earlier and moves faster in people with Down syndrome. The finding may have important implications for the treatment and care of this vulnerable group of patients. April 16, 2024 Published In Newsroom Stories Alzheimer's Immunotherapy for Alzheimer’s disease shows promise in mouse study Researchers at Washington University School of Medicine in St. Louis have found a different and promising way to remove amyloid beta plaques in the brain: by directly mobilizing immune cells to consume them. The study was published in Science Translational Medicine. April 3, 2024 Published In Newsroom Stories Public Health Social determinants of health increase Alzheimer&＃8217;s risk Social determinants of health are increasing Alzheimer&＃8217;s disease and related dementia risk, finds a recent study from the Brown School and the School of Medicine at Washington University in St. Louis. March 5, 2024 Published In Record Neuroscience & Memory Neurons help flush waste out of brain during sleep Scientists at Washington University School of Medicine in St. Louis have found that brain waves help flush waste out of the brain during sleep. The findings could lead to new approaches for treating Alzheimer’s disease and other neurological conditions. February 28, 2024 Published In Newsroom Stories Neuroscience & Memory Two WashU faculty awarded Sloan Research Fellowships Two early-career Washington University faculty members have been awarded a prestigious Sloan Research Fellowship: psychologist Zachariah Reagh, in Arts &＃038; Sciences, and neuroscientist Gaia Tavoni, at the School of Medicine. February 22, 2024 Published In Record Alzheimer's Alzheimer’s blood test performs as well as FDA-approved spinal fluid tests Researchers at Washington University School of Medicine in St. Louis and Lund University in Sweden showed that a blood test is as good at identifying people in early stages of the disease as cerebrospinal fluid tests approved by the Food and Drug Administration for Alzheimer’s diagnosis. February 21, 2024 Published In Newsroom Stories Older Stories Posts navigation Older Stories Publications Washington Magazine Newsroom Record Explore Bookshelf Video Gallery Connect Media Resources Contact Facebook Instagram ©2024 Washington University in St. Louis Go back to top